Open access · OA
via OpenAlex
Biology and relevance of human acute myeloid leukemia stem cells
DANIEL W. THOMAS, Ravindra Majeti
Blood · 2017 · ▲ 539 citations
Abstract
Evidence of human acute myeloid leukemia stem cells (AML LSCs) was first reported nearly 2 decades ago through the identification of rare subpopulations of engrafting cells in xenotransplantation assays. These AML LSCs were shown to reside at the apex of a cellular hierarchy that initiates and maintains the disease, exhibiting properties of self-renewal, cell cycle quiescence, and chemoresistance. This cancer stem cell model offers an explanation for chemotherapy resistance and disease relapse and implies that approaches to treatment must eradicate LSCs for cure. More recently, a number of studies have both refined and expanded our understanding of LSCs and intrapatient heterogeneity in AML using improved xenotransplant models, genome-scale analyses, and experimental manipulation of primary patient cells. Here, we review these studies with a focus on the immunophenotype, biological properties, epigenetics, genetics, and clinical associations of human AML LSCs and discuss critical questions that need to be addressed in future research.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1182/blood-2016-10-696054
- Canonical
- link ↗
- Fetched
- 2026-10-03 MST
Cite this
APA
THOMAS, D.W., & Majeti, R. (2017). Biology and relevance of human acute myeloid leukemia stem cells. <em>Blood</em>. https://doi.org/10.1182/blood-2016-10-696054
Vancouver
THOMAS DW, Majeti R. Biology and relevance of human acute myeloid leukemia stem cells. Blood. 2017. doi:10.1182/blood-2016-10-696054.
BibTeX
@article{daniel2017Biolog,
title = {Biology and relevance of human acute myeloid leukemia stem cells},
author = {DANIEL W. THOMAS and Ravindra Majeti},
journal = {Blood},
year = {2017},
doi = {10.1182/blood-2016-10-696054},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Europe PMC (PubMed Central) 2012
Preprint · OA
Mesenchymal stem cells, aging and regenerative medicine.
Disease Models & Mechanisms 2010
Open access · OA
Potential and pitfalls of stem cell therapy in old age
International Journal of Hematology 2014
Open access · OA
Cancer gene therapy using mesenchymal stem cells
Nature Communications 2021
Open access · CC-BY
Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics
Frontiers in Bioengineering and Biotechnology 2020
Open access · CC-BY
Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy
eScholarship (California Digital Library) 2017
Preprint · OA